DK0835252T3 - Antifungale triazolforbindelser - Google Patents

Antifungale triazolforbindelser

Info

Publication number
DK0835252T3
DK0835252T3 DK96921941T DK96921941T DK0835252T3 DK 0835252 T3 DK0835252 T3 DK 0835252T3 DK 96921941 T DK96921941 T DK 96921941T DK 96921941 T DK96921941 T DK 96921941T DK 0835252 T3 DK0835252 T3 DK 0835252T3
Authority
DK
Denmark
Prior art keywords
triazole compounds
antifungal triazole
antifungal
compounds
triazole
Prior art date
Application number
DK96921941T
Other languages
Danish (da)
English (en)
Inventor
Michael Jonathan Fray
Andrew Simon Bell
Alan Patrick Marchington
Kenneth Richardson
Peter Thomas Stephenson
Peter John Whittle
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Application granted granted Critical
Publication of DK0835252T3 publication Critical patent/DK0835252T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK96921941T 1995-06-26 1996-06-05 Antifungale triazolforbindelser DK0835252T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9512961.5A GB9512961D0 (en) 1995-06-26 1995-06-26 Antifungal agents
PCT/EP1996/002470 WO1997001552A1 (en) 1995-06-26 1996-06-05 Triazole antifungal agents

Publications (1)

Publication Number Publication Date
DK0835252T3 true DK0835252T3 (da) 2003-10-27

Family

ID=10776672

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96921941T DK0835252T3 (da) 1995-06-26 1996-06-05 Antifungale triazolforbindelser

Country Status (25)

Country Link
US (1) US6015825A (xx)
EP (1) EP0835252B1 (xx)
JP (1) JP3105926B2 (xx)
KR (1) KR19990028390A (xx)
AR (1) AR002761A1 (xx)
AT (1) ATE246186T1 (xx)
AU (1) AU697405B2 (xx)
BR (1) BR9609298A (xx)
CA (1) CA2224983C (xx)
CO (1) CO4480719A1 (xx)
CZ (1) CZ415597A3 (xx)
DE (1) DE69629300T2 (xx)
DK (1) DK0835252T3 (xx)
ES (1) ES2202453T3 (xx)
GB (1) GB9512961D0 (xx)
HU (1) HUP9803022A2 (xx)
IL (1) IL118698A0 (xx)
NO (1) NO976047L (xx)
NZ (1) NZ311651A (xx)
PE (1) PE4698A1 (xx)
PL (1) PL324336A1 (xx)
PT (1) PT835252E (xx)
TR (1) TR199701699T1 (xx)
WO (1) WO1997001552A1 (xx)
ZA (1) ZA965365B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602080D0 (en) 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
GB9713149D0 (en) 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
US6645990B2 (en) 2000-08-15 2003-11-11 Amgen Inc. Thiazolyl urea compounds and methods of uses
KR100572996B1 (ko) * 2003-08-12 2006-04-25 한국화학연구원 불소화 비닐 에테르 측쇄기를 갖는 아졸계 살균제 화합물및 그의 제조방법
KR101164258B1 (ko) 2003-12-23 2012-07-11 아스텍스 테라퓨틱스 리미티드 단백질 키나아제 조절제로서의 피라졸 유도체
WO2006136821A1 (en) 2005-06-22 2006-12-28 Astex Therapeutics Limited Pharmaceutical compounds
US8541461B2 (en) 2005-06-23 2013-09-24 Astex Therapeutics Limited Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
KR100738228B1 (ko) * 2006-02-22 2007-07-12 한국화학연구원 아졸계 항균제 화합물 및 그의 제조방법
GB0704932D0 (en) 2007-03-14 2007-04-25 Astex Therapeutics Ltd Pharmaceutical compounds
PT2563771E (pt) * 2010-04-24 2016-03-31 Viamet Pharmaceuticals Inc Compostos inibidores de metaloenzimas
WO2012052412A1 (de) 2010-10-22 2012-04-26 Bayer Cropscience Ag Neue heterocylische verbindungen als schädlingsbekämpfungsmittel
WO2012123952A1 (en) * 2011-03-15 2012-09-20 Fdc Limited Enantiomers of fluconazole analogues containing thieno-[2,3-d]pyrimidin-4(3h)-one moiety as antifungal agents
BR102012015199A2 (pt) 2011-06-19 2014-05-13 Viamet Pharmaceuticals Inc Compostos inibidores de metaloenzima
CN103857675A (zh) * 2011-06-23 2014-06-11 威尔金制药有限公司 金属酶抑制剂化合物
PL2804858T3 (pl) 2012-01-20 2020-06-29 Mycovia Pharmaceuticals, Inc. Związki - inhibitory metaloenzymu
TWI646088B (zh) * 2012-03-16 2019-01-01 維愛美製藥公司 金屬酶抑制劑化合物
WO2013144224A1 (en) * 2012-03-27 2013-10-03 Syngenta Participations Ag Acetylenic microbiocides
EP3044212B1 (en) * 2013-09-13 2017-11-29 Suven Life Sciences Limited Process for the large scale production of 1h- [1,2,3]triazole and its intermediate 1-benzyl-1h-[1,2,3]triazole

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729523A (en) * 1984-06-11 1988-03-08 Kabushiki Kaisha Tokai-Rika-Denki-Seisakusho Locking mechanism for webbing retractor
GB8819308D0 (en) * 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
GB9107055D0 (en) * 1991-04-04 1991-05-22 Pfizer Ltd Triazole antifungal agents
GB9121456D0 (en) * 1991-10-10 1991-11-27 Pfizer Ltd Triazole antifungal agents
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
CA2145458A1 (en) * 1994-03-28 1995-09-29 Hiroki Kodama Triazole compound and production process and use thereof

Also Published As

Publication number Publication date
PL324336A1 (en) 1998-05-25
BR9609298A (pt) 1999-05-18
AU697405B2 (en) 1998-10-08
MX9800046A (es) 1998-08-30
IL118698A0 (en) 1996-10-16
CA2224983C (en) 2003-04-08
CO4480719A1 (es) 1997-07-09
AR002761A1 (es) 1998-04-29
EP0835252A1 (en) 1998-04-15
NZ311651A (en) 1999-09-29
PE4698A1 (es) 1998-03-03
US6015825A (en) 2000-01-18
ATE246186T1 (de) 2003-08-15
JPH10506652A (ja) 1998-06-30
NO976047L (no) 1998-02-25
NO976047D0 (no) 1997-12-22
DE69629300D1 (de) 2003-09-04
WO1997001552A1 (en) 1997-01-16
EP0835252B1 (en) 2003-07-30
CZ415597A3 (cs) 1998-11-11
ES2202453T3 (es) 2004-04-01
PT835252E (pt) 2003-11-28
DE69629300T2 (de) 2004-03-04
ZA965365B (en) 1997-12-29
GB9512961D0 (en) 1995-08-30
AU6301096A (en) 1997-01-30
HUP9803022A2 (hu) 1999-10-28
TR199701699T1 (xx) 1998-06-22
JP3105926B2 (ja) 2000-11-06
KR19990028390A (ko) 1999-04-15
CA2224983A1 (en) 1997-01-16

Similar Documents

Publication Publication Date Title
ID16345A (id) Senyawa-senyawa heterosiklik
DK0861235T3 (da) Substituerede benzylaminopiperidinforbindelser
NO980570L (no) Parasitticidale forbindelser
ZA962319B (en) Fungicidal compounds
DK0835256T3 (da) Mikrobicide benzotriazoler
DK0753001T3 (da) Antifungale sordaridinderivater
DK0835252T3 (da) Antifungale triazolforbindelser
BR9607925A (pt) Composição fungicida
IS4739A (is) Efnasambönd
FI963297A (fi) Antifungaalisia triatsolijohdannaisia sisältävät emulsiot
NO974170D0 (no) Polyazacykloalkan-forbindelser
DE69603581D1 (de) Fungizide mischungen
DE59604140D1 (de) Fungizide mischungen
ATE209857T1 (de) Fungizide mischungen
ZA962317B (en) Fungicidal compounds
IL119567A0 (en) Fungicidal compounds
DE69614542D1 (de) Fungizide mischungen
GB9523316D0 (en) Fungicidal compounds
GB9523001D0 (en) Fungicidal compounds
GB9502866D0 (en) Fungicidal compounds
GB9502865D0 (en) Fungicidal compounds
GB9523332D0 (en) Fungicidal compounds
ITMI950031A0 (it) Composti dibenzoalchilenici
BR1100842A (pt) Compostos